SunAct - Advanced Cancer Therapies, the oncology startup founded by Dr Vijay Patil and Dr Ashay Karpe, aimed at making the world’s most advanced and innovative cancer care accessible and affordable in the country, has launched its third facility in India and the first in Mumbai city, at the Dr. Gupte Surgical Hospital in Khar (West). The new centre will offer India’s first CAR-T cell therapy for solid-state tumours along with various therapies which will be introduced in India via SunAct.
SunAct's Khar centre will not only offer CAR-T for haematological cancers like Lymphoma, Leukemia and Myeloma, but it is also India’s first CAR T-cell therapy for solid tumours, a revolutionary approach previously unavailable in the country.
In addition to this milestone, the centre will provide TCR (T-Cell Receptor) Therapies; TIL (Tumor-Infiltrating Lymphocyte) Therapies; Gamma Delta T-Cell Platforms; Gene Therapies; Bone Marrow Transplantation & Clinical Trials.
Addressing a question on SunAct’s plans for the future, Kushagra Sharma, CEO, SunAct-Advanced Cancer Therapies said, “We definitely aim to expand all over India including in Maharashtra. The idea is to spread awareness through marketing, through social media and also to spread awareness among more and more doctors that these treatments are now available in India.”
